Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)

Molecular Pharmacology

Volumn 53, Issue 2, 1998, Pages 340-345

  Esté, José A ^a,b   Cabrera, Cecilia ^a   Schols, Dominique ^b   Cherepanov, Peter ^b   Gutierrez, Arantxa ^a   Witvrouw, Myriam ^b   Pannecouque, Christophe ^b   Debyser, Zeger ^b   Rando, Robert F ^c   Clotet, Bonaventura ^a   Desmyter, Jan ^b   De Clercq, Erik ^b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c Antigenics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; ZINTEVIR;

ANTIVIRAL ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0031886388     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.2.340     Document Type: Article

References (23)

1. Bridger, GJ, Skerlj RT, Thornton D, Padmanabhan S, Martellucci SA, Henson GW, Abrams MJ, Yamamoto N, De Vreese K, Pauwels R, and De Clercq E (1995) Synthesis and structure-activity relationship of phenylenebis-(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effect of macrocyclic ring size and substituents on the aromatic linker. J Med Chem 38:366-378.
2. Buckheit RW, Roberson JL, Lackman-Smith C, Wyatt JR, Vickers TA, and Ecker DJ (1994) Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS5320). AIDS Res Hum Retrovir 10:1497-1506.
3. Cherepanov P, Esté JA, Rando RF, Reekmans G, David G, De Clercq E, and Debyser Z (1997) Interaction of human immunodeficiency virus-1 integrase with guanosine-quartet forming oligonucleotides. Mol Pharmacol 52:771-780.
4. + T cells. Science (Washington DC) 270:1811-1815.
5. De Vreese, K, Kofler-Mongold V, Leutgeb C, Weber V, Vermeire K, Schacht S, Anné J, De Clercq E, Datema R, and Werner G (1996a) The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. J Virol 70:689-696.
6. De Vreese K, Reymen D, Griffin P, Steinkasserer A, Werner G, Bridger G, Esté J, James W, Henson GW, Desmyter J, Anné J, and De Clercq E (1996b) The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding. Antiviral Res 29:209-219.
7. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
8. Esté, JA, Schols D, De Vreese K, Van Laethem K, Vandamme AM, Desmyter J, and De Clercq E (1997) Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein. Mol Pharmacol 52:98-104.
9. Esté JA, De Vreese K, Witvrouw M, Schmit JC, Vandamme AM, Anné J, Desmyter J, Henson GW, Bridger G, and De Clercq E (1996) Antiviral activity of the bicyclam AMD3100 against drug-resistant strains of human immunodeficiency virus type 1. Antiviral Res 29:297-307.
10. Feng Y, Broder CC, Kennedy PE, and Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (Washington DC) 272:872-877.
11. Fischer PB, Collin M, Karlsson GB, James W, Butters TD, Davis SJ, Gordon S, Dwek RA, and Platt FM (1995) The α-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J Virol 69:5791-5797.
12. Gallagher WR, Ball J, Garry J, Martin-Amedee A, and Montelaro R (1995) A general model for the surface glycoprotein of HIV and other retroviruses. AIDS Res Hum Retrovir 11:191-202.
13. Harada S, Koyanagi Y, and Yamamoto N (1985) Infection of HTLV-IIIB/LAV in HTLV-I-carrying cells MT-2 and MT-4: an application in a plaque assay. Science (Washington DC) 229:563-566.
14. Mazumder A, Neamati N, Ojwang JO, Sunder S, Rando RF, and Pommier Y (1996) Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures. Biochemistry 35:13762-13771.
15. + cells. Science (Washington DC) 240:646-648.
16. Ojwang JO, Buckheit R, Pommier Y, Mazumder A, De Vreese K, Esté JA, Reymen D, Pallansch L, Lackman-Smith C, Wallace T, De Clercq E, McGrath M, and Rando RF (1995) T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Antimicrob Agents Chemother 39:2426-2435.
17. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, and De Clercq E (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20:309-321.
18. Rando RF, Ojwang J, Elbaggari A, Reyes JR, Tinder R, McGrath MS, and Hogan ME (1995) Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads. J Biol Chem 270:1754-1760.
19. Schols D, Pauwels R, Desmyter J, and De Clercq E (1990) Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology 175:556-561.
20. Schols D, Struyf S, Van Damme J, Esté JA, Henson G, and De Clercq E (1997) Inhibition of T-tropic HTV strains by selective antagonism of the chemokine receptor CXCR4. J Exp Med, in press.
21. Tamamura H, Otaka A, Murakami T, Ishihara T, Ibuka T, Waki M, Matsumoto A, Yamamoto N, and Fuji N (1996) Interaction of an anti-HIV peptide T22, with gp120 and CD4. Biochem Biophys Res Commun 219:555-559.
22. Witvrouw M, Esté JA, Quiñones-Mateu M, Reymen D, Andrei G, Snoeck R, Ikeda S, Pauwels R, Bianchini N, Desmyter J, and De Clercq E (1994) Activity of a sulfated polysaccharide extracted from the red seaweed Aghardiella tenera against human immunodeficiency virus and other enveloped viruses. Antiviral Chem Chemother 5:297-303.
23. Wyatt JR, Vickers TA, Roberson JL, Buckheit RW, Klimkait JT, De Baets E, Davis PW, Rayner B and Imbach JL (1994) Combinatorially selected guanosine -quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc Natl Acad Sci USA 91:1356-1360.